Elusys begins human trial of anthrax treatment
Anthim was granted fast track status by the FDA on May 6th 2005, and this study will begin in the coming weeks. The company has also initiated manufacturing
Japan-based Ono Pharmaceutical has signed an agreement with US biotechnology company Aitia to collaborate on drug discovery in neurological diseases.
FM-VP4 is a cholesterol absorption inhibitor, a new class in cholesterol-lowering drugs. FM-VP4 has demonstrated significant cholesterol-lowering and anti-atherosclerotic properties in pre-clinical studies. The cardiovascular market represents a